Chargement en cours...
Potential Benefits of Pre-emptive PGx Testing in Male Breast Cancer Patients
The objective is to report a case of recurrent breast cancer in a poor CYP2D6 metabolizer male patient on tamoxifen, and how pharmacogenomic (PGx) testing can play an important role in selecting appropriate adjuvant endocrine therapy. The case examined here is a 60-year-old white male diagnosed with...
Enregistré dans:
| Publié dans: | Innov Pharm |
|---|---|
| Auteurs principaux: | , , |
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
University of Minnesota Libraries Publishing
2019
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8051901/ https://ncbi.nlm.nih.gov/pubmed/34007593 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.24926/iip.v10i4.2303 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|